In The News
University of Arizona Sarver Heart Center Assistant Professor of Medicine Michel Corban, MD sat down with KOLD News 13 for an interview on SCAD.
"Science is super fun and I love it, but I really love helping others with their career development,” Dr. Nancy Sweitzer said. “It’s the No. 1 pleasure in my job.”
Training to become a cardiologist takes a lot of time, patience and guidance. But with advanced technology in the form of the College of Medicine – Tucson Sarver Heart Center’s Harveys – animatronic devices capable of being programmed with a wide range of heart beats and health issues – future cardiologists are able to learn what to listen for and how to treat heart ailments.
The partnership between a basic scientist and a clinical researcher is a setup that permeates the center’s culture and its success, breaking down walls that can stand between disciplines. “I like to call the Sarver Heart Center the intellectual home for people working in cardiovascular medicine, no matter what their department affiliation,” Dr. Nancy Sweitzer said.
Dr. Julia Indik, a the late-breaking clinical trials panelist at the virtual ACC2021 conference, comments on the Prague OHCA clinical trial, a “hyperinvasive” approach to treating cardiac arrest, including mechanical chest compressions during transport and extracorporeal CPR, if needed, followed by swift invasive tests and treatment.
The editorial team of Circulation: Cardiovascular Quality and Outcomes issued a statement urging scientific journals to address racial/ethnic disparities prevalent in health science research, particularly cardiovascular trials. Dr. Khadijah Breathett is the corresponding author.
While it isn’t clear that the increase is tied to COVID-19 or the financial and emotional stresses of the pandemic, Dr. Nancy Sweitzer recommends people practice self care to reduce stress that could lead to "broken heart syndrome.".
Myocarditis, inflammation of the heart muscle, and vascular inflammation, inflammation of all the blood vessels in the body, are conditions seen in post-COVID-19 patients, Dr. Nancy Sweitzer tells the Arizona Daily Wildcat. Blood clots unlike any she has seen before line entire blood vessels or clot in the arteries in the heart; several patients are coming in who’ve had COVID-19 three, four, even six weeks ago.
To encourage minority populations to participate in clinical trials, they must be ethically sound, with education and respect for the privacy rights of all participants, writes Wanda F. Moore, chair of the Sarver Heart Center Minority Outreach Program.
The process of allocating heart therapies is biased. It's a structural problem. Dr. Khadijah Breathett invites clinicians to work on the structural solutions.